These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7109183)

  • 41. Update on adult immunizations.
    Wolfe RM
    J Am Board Fam Med; 2012; 25(4):496-510. PubMed ID: 22773718
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Vaccines inf the prevention of fecal hazards].
    Saliou P
    Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):445-9. PubMed ID: 10078383
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Supplementary report: surveillance of adverse events following immunisation among children aged less than 7 years in Australia, 1 January to 30 June 2007.
    Lawrence GL; Aratchige PE; Hill R
    Commun Dis Intell Q Rep; 2007 Dec; 31(4):379-82. PubMed ID: 18268878
    [No Abstract]   [Full Text] [Related]  

  • 44. Replacement of animals in manufacture and control of vaccines.
    Hennessen W
    Dev Biol Stand; 1980; 45():163-73. PubMed ID: 6772505
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adult immunization. Recommendations of the Immunization Practices Advisory Committee. (ACIP).
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1984 Sep; 33 Suppl 1():1S-68S. PubMed ID: 6436675
    [No Abstract]   [Full Text] [Related]  

  • 46. Guidelines for control of meningococcal disease. Laboratory Centre for Disease Control. Canadian Consensus Conference on Meningococcal Disease.
    CMAJ; 1994 Jun; 150(11):1825-39. PubMed ID: 8199959
    [No Abstract]   [Full Text] [Related]  

  • 47. Childhood vaccine development: an overview.
    Baker JP; Katz SL
    Pediatr Res; 2004 Feb; 55(2):347-56. PubMed ID: 14630981
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lessons from preventive infectious disease vaccines.
    Chandler DK; Midthun K; Goldenthal KL
    Dev Biol (Basel); 2004; 116():61-6; discussion 69-76. PubMed ID: 15603184
    [TBL] [Abstract][Full Text] [Related]  

  • 49. From the Centers for Disease Control and Prevention. Pneumococcal and influenza vaccination levels among adults aged > or = 65 years--United States, 1995.
    JAMA; 1997 Oct 22-29; 278(16):1306-7. PubMed ID: 9343446
    [No Abstract]   [Full Text] [Related]  

  • 50. Vaccination of adults with asthma and COPD.
    Pesek R; Lockey R
    Allergy; 2011 Jan; 66(1):25-31. PubMed ID: 20716316
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vaccinology in the prophylaxis of respiratory infections--Part II.
    Griffin JP
    Clin Notes Respir Dis; 1978; 17(2):3-12. PubMed ID: 699411
    [No Abstract]   [Full Text] [Related]  

  • 52. Surveillance for acute viral hepatitis - United States, 2007.
    Daniels D; Grytdal S; Wasley A;
    MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
    [TBL] [Abstract][Full Text] [Related]  

  • 53. From the Centers for Disease Control and Prevention. Pneumococcal and influenza vaccination levels among adults aged > or = 65 years--United States, 1993.
    JAMA; 1996 Nov; 276(19):1544-5. PubMed ID: 8918840
    [No Abstract]   [Full Text] [Related]  

  • 54. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations.
    Butler JC; Breiman RF; Campbell JF; Lipman HB; Broome CV; Facklam RR
    JAMA; 1993 Oct; 270(15):1826-31. PubMed ID: 8411526
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Report from the CDC. Vaccines in women.
    Schmidt JV; Kroger AT; Roy SL
    J Womens Health (Larchmt); 2004 Apr; 13(3):249-57. PubMed ID: 15130253
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vaccination of preterm infants by polyvalent vaccines: immunogenicity and safety- review of literature.
    Czajka H; Lauterbach R; Pawlik D
    Dev Period Med; 2014; 18(3):360-6. PubMed ID: 25182401
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vaccine schedules and procedures.
    Middleton DB; Zimmerman RK; Mitchell KB
    J Fam Pract; 2005 Jan; 54(1 Suppl):S37-50. PubMed ID: 15623393
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Are vaccines for children safe enough?].
    Heilmann CJ
    Ugeskr Laeger; 2000 Aug; 162(34):4513. PubMed ID: 10981214
    [No Abstract]   [Full Text] [Related]  

  • 59. Supplementary report: surveillance of adverse events following immunisation among children aged less than 7 years in Australia, 1 January to 30 June 2005.
    Lawrence G; Boyd I
    Commun Dis Intell Q Rep; 2005; 29(4):413-6. PubMed ID: 16465935
    [No Abstract]   [Full Text] [Related]  

  • 60. Seroprevalence of common vaccine-preventable viral infections in HIV-positive adults.
    Molton J; Smith C; Chaytor S; Maple P; Brown K; Johnson M; Geretti AM
    J Infect; 2010 Jul; 61(1):73-80. PubMed ID: 20403382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.